There are 511 resources available
99P - Circulating tumor DNA is prognostic for disease-free survival in patients with metastatic colorectal cancer undergoing definitive therapy
Presenter: Nikolas Naleid
Session: Poster Display session
Resources:
Abstract
100P - Analysis of intraarterial chemotherapy schemes and its outcomes for liver metastases of colorectal cancer
Presenter: Kateryna Cherchenko
Session: Poster Display session
Resources:
Abstract
101P - Predictive and prognostic factors of bone and brain metastases of metastatic colorectal cancer in the era of biomarker-driven therapy
Presenter: Yuko Fukumoto
Session: Poster Display session
Resources:
Abstract
102P - Real-world data on overall and progression-free survival for patients (pts) with metastatic colorectal cancer (mCRC) for the United Kingdom (UK) cohort of the PROMETCO study (PROMETCO-UK)
Presenter: Francisca Marti Marti
Session: Poster Display session
Resources:
Abstract
103P - Prognosis analysis in oligometastatic colorectal cancer with systemic therapy and iodine-125 seed implantation: A retrospective study
Presenter: Dengyao LIU
Session: Poster Display session
Resources:
Abstract
104P - A real-world study: Efficacy of the third-line therapy of standard therapy versus rechallenge-chemotherapy in refractory metastatic colorectal cancer
Presenter: Xifeng Xu
Session: Poster Display session
Resources:
Abstract
105P - Prognostic value of PIK3CA gene assessment in tissue & plasma in metastatic colorectal cancer (mCRC)
Presenter: Eduardo Terán Brage
Session: Poster Display session
Resources:
Abstract
106P - Retrospective analysis of the impact of relative dose intensity on outcomes of colorectal cancer patients treated with 5-FU-based chemotherapy
Presenter: jianfei fu
Session: Poster Display session
Resources:
Abstract
107P - Results of metastatic directed therapy (MDT) performed with brachytherapy/interventional radiotherapy in patients with liver metastases from colorectal cancer in repeat oligopersistence clinical scenario: A single institution retrospective analysis
Presenter: Mateusz Bilski
Session: Poster Display session
Resources:
Abstract
108P - Negative hyperselection and mechanisms of acquired resistance to first-line chemotherapy plus anti-EGFR in pMMR RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts): A translational analysis of the TRIPLETE trial
Presenter: Veronica Conca
Session: Poster Display session
Resources:
Abstract